Targeting iron–sulfur cluster assembly scaffold protein as a vulnerability in KRAS‐activated pancreatic ductal adenocarcinoma

Targeting iron–sulfur cluster assembly scaffold protein as a vulnerability in KRAS‐activated pancreatic ductal adenocarcinoma

Bibliographic Details
Main Authors:	Huarui Cai, Hongjuan Cui, Erhu Zhao
Format:	Article
Language:	English
Published:	Wiley 2024-03-01
Series:	MedComm – Oncology
Online Access:	https://doi.org/10.1002/mog2.65

Similar Items

KRAS-related noncoding RNAs in pancreatic ductal adenocarcinoma
by: Shuang-Ni Yu, et al.
Published: (2016-12-01)

Targeting KRAS in Pancreatic Ductal Adenocarcinoma: The Long Road to Cure
by: Victor Hugo Fonseca de Jesus, et al.
Published: (2023-10-01)

KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression
by: Zining Zhang, et al.
Published: (2023-04-01)

Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma
by: Yu-Huei Liu, et al.
Published: (2022-09-01)

KRAS-Dependency in Pancreatic Ductal Adenocarcinoma: Mechanisms of Escaping in Resistance to KRAS Inhibitors and Perspectives of Therapy
by: Enrico Gurreri, et al.
Published: (2023-05-01)

Notch1 is not required for acinar-to-ductal metaplasia in a model of Kras-induced pancreatic ductal adenocarcinoma.
by: Jacqueline L Avila, et al.
Published: (2012-01-01)

The Clinical Implications of KRAS Mutations and Variant Allele Frequencies in Pancreatic Ductal Adenocarcinoma
by: Faria Nusrat, et al.
Published: (2024-04-01)

Exploring KRAS-mutant pancreatic ductal adenocarcinoma: a model validation study
by: Fan Yang, et al.
Published: (2024-01-01)

Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma
by: Abdelrahman Yousef, et al.
Published: (2024-02-01)

Genomic landscape of clinically advanced KRAS wild-type pancreatic ductal adenocarcinoma
by: Prashanth Ashok Kumar, et al.
Published: (2023-06-01)

KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities
by: Claudio Luchini, et al.
Published: (2020-10-01)

<i>KRAS</i> Mutation Dictates the Cancer Immune Environment in Pancreatic Ductal Adenocarcinoma and Other Adenocarcinomas
by: Meichen Gu, et al.
Published: (2021-05-01)

Differential Effects of Dietary Macronutrients on the Development of Oncogenic KRAS-Mediated Pancreatic Ductal Adenocarcinoma
by: Liang Zhu, et al.
Published: (2022-05-01)

Mechanism of Iron–Sulfur Cluster Assembly: In the Intimacy of Iron and Sulfur Encounter
by: Batoul Srour, et al.
Published: (2020-10-01)

Assembly and Transfer of Iron–Sulfur Clusters in the Plastid
by: Yan Lu
Published: (2018-03-01)

Integrative analysis of KRAS wildtype metastatic pancreatic ductal adenocarcinoma reveals mutation and expression-based similarities to cholangiocarcinoma
by: James T. Topham, et al.
Published: (2022-10-01)

The role of CyaY in iron sulfur cluster assembly on the E. coli IscU scaffold protein.
by: Clara Iannuzzi, et al.
Published: (2011-01-01)

THE SUBTYPES OF PANCREATIC DUCTAL ADENOCARCINOMAS
by: Apeksha Kakkar, et al.
Published: (2016-12-01)

Syndecans and Pancreatic Ductal Adenocarcinoma
by: Nausika Betriu, et al.
Published: (2021-02-01)

Pancreatic Ductal Adenocarcinoma Associated with Autoimmune Pancreatitis
by: Raffaele Pezzilli, et al.
Published: (2011-07-01)

Bridging a gap in iron-sulfur cluster assembly
by: Erin L. McCarthy, et al.
Published: (2015-09-01)

TP53 missense mutation reveals gain-of-function properties in small-sized KRAS transformed pancreatic ductal adenocarcinoma
by: Yiran Zhou, et al.
Published: (2023-12-01)

Anemia, Iron Deficiency, and Iron Regulators in Pancreatic Ductal Adenocarcinoma Patients: A Comprehensive Analysis
by: Malgorzata Osmola, et al.
Published: (2023-08-01)

Identification and validation of stemness-based and ferroptosis-related molecular clusters in pancreatic ductal adenocarcinoma
by: Shiye Ruan, et al.
Published: (2024-03-01)

The T-cell architecture of pancreatic ductal adenocarcinoma
by: Sivakumar, S, et al.
Published: (2019)

The T cell architecture of pancreatic ductal adenocarcinoma
by: Sivakumar, S, et al.
Published: (2019)

Ubiquitin signaling in pancreatic ductal adenocarcinoma
by: Shengnan Lv, et al.
Published: (2023-12-01)

Surgical Treatment of Pancreatic Ductal Adenocarcinoma
by: Kongyuan Wei, et al.
Published: (2021-04-01)

Advances in Immunotherapeutics in Pancreatic Ductal Adenocarcinoma
by: Tarak Chouari, et al.
Published: (2023-08-01)

An Immunological Glance on Pancreatic Ductal Adenocarcinoma
by: Michael Karl Melzer, et al.
Published: (2020-05-01)

Photodynamic Therapy for Pancreatic Ductal Adenocarcinoma
by: Vida Karimnia, et al.
Published: (2021-08-01)

Advances in Pancreatic Ductal Adenocarcinoma Treatment
by: Eric M. Anderson, et al.
Published: (2021-11-01)

Surgical Treatment of Pancreatic Ductal Adenocarcinoma
by: Sohei Satoi
Published: (2021-08-01)

Molecular imaging of pancreatic ductal adenocarcinoma
by: Wei Huang, et al.
Published: (2023-10-01)

Oral mycobiota and pancreatic ductal adenocarcinoma
by: Ailin Wei, et al.
Published: (2022-12-01)

Metabolism remodeling in pancreatic ductal adenocarcinoma
by: Jin-Tao Li, et al.
Published: (2019-11-01)

Apoptotic pathways in pancreatic ductal adenocarcinoma
by: Saur Dieter, et al.
Published: (2008-07-01)

Targeting Pancreatic Ductal Adenocarcinoma (PDAC)
by: Sofia Parrasia, et al.
Published: (2021-01-01)

Inhibition of KRAS, MEK and PI3K Demonstrate Synergistic Anti-Tumor Effects in Pancreatic Ductal Adenocarcinoma Cell Lines
by: Yixuan Ma, et al.
Published: (2022-09-01)

Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma.
by: Ole Helm, et al.
Published: (2014-01-01)